News - BioCryst Pharmaceuticals


Current filters:

BioCryst Pharmaceuticals

Popular Filters

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva


Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before…

BioCryst PharmaceuticalsFinancialHomeMergers & AcquisitionsNestlePfizerPresidio PharmaceuticalsTeva Pharmaceutical Industries

BioCryst withdraws BCX5191 lND following discussion with FDA


US biotech firm BioCryst Pharmaceuticals (Nasdaq: BCRX) says it is withdrawing its Investigational New…

Anti-viralsBCX5191BioCryst PharmaceuticalsBiotechnologyNorth AmericaRegulationResearch

BioCryst and Presidio to merge, creating new competitor in HCV arena


USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top